WellPoint, Inc. issued the following points of clarification in response to the Reuters article regarding their treatment of breast cancer patients: "The Reuters story alleging that WellPoint employs a targeted rescission policy for members with breast cancer is inaccurate and grossly misleading. The story incorrectly reports that WellPoint singles out women with breast cancer for aggressive investigation with the intent of canceling their insurance. This is simply wrong. In fact, WellPoint works to prevent breast cancer, to detect it early, and to get our members into treatment. We also work to ensure that all of our members are getting best practice care for breast cancer."

For the rest of the story, visit Insurance Newscast (www.insurancebroadcasting.com)